Page last updated: 2024-09-05

clorazepate dipotassium and Symptom Cluster

clorazepate dipotassium has been researched along with Symptom Cluster in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferrer-Dufol, A; Marques-Alamo, JM; Murillo, EC; Perez-Aradros, C1
Bourgeois, M; Daubech, JF; Delile, JM; Goumilloux, R; Jordan, M; Rigal, F1

Other Studies

2 other study(ies) available for clorazepate dipotassium and Symptom Cluster

ArticleYear
Fatal serotonin syndrome caused by moclobemide-clomipramine overdose.
    Journal of toxicology. Clinical toxicology, 1998, Volume: 36, Issue:1-2

    Topics: Adult; Benzamides; Clomipramine; Clorazepate Dipotassium; Drug Interactions; Drug Overdose; Fatal Outcome; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Syndrome

1998
[Depersonalization, Cotard's syndrome and tendency toward mania under benzodiazepine (apropos of 2 case reports)].
    Annales medico-psychologiques, 1986, Volume: 144, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Clorazepate Dipotassium; Depersonalization; Female; Humans; Paranoid Personality Disorder; Personality Disorders; Psychoses, Substance-Induced; Syndrome

1986